MedPath
NMPA Approval

Hydrotalcite Suspension

国药准字H20254454

June 3, 2025

Drug Information

铝碳酸镁混悬液

口服混悬剂

10ml:1g

化学药品

June 3, 2025

Company Information

Applicant Company

重庆市南岸区花园路街道大石路53号2层1号、2号

Manufacturing Company

贵州省贵阳市修文县扎佐医药工业园区B区磨秧坡

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.